Editas Medicine Ownership | Who Owns Editas Medicine?
Editas Medicine Ownership Summary
Editas Medicine is owned by 43.61% institutional investors, 0.27% insiders, and 56.12% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.44% of EDIT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.12% of its assets in Editas Medicine shares.
EDIT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Editas Medicine | 43.61% | 0.27% | 56.12% |
| Sector | Healthcare Stocks | 232.80% | 10.63% | -143.43% |
| Industry | Biotech Stocks | 379.48% | 10.37% | -289.85% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 9.26M | 10.44% | $22.88M |
| Blackrock | 7.78M | 9.50% | $36.34M |
| Vanguard group | 8.21M | 9.11% | $16.83M |
| Renaissance | 3.97M | 4.48% | $9.81M |
| Geode capital management | 2.31M | 2.60% | $5.71M |
| State street | 2.08M | 2.34% | $5.13M |
| Nuveen | 1.98M | 2.23% | $4.88M |
| Jpmorgan chase | 1.95M | 2.19% | $4.34M |
| D. e. shaw | 1.94M | 2.19% | $4.80M |
| Opaleye management | 1.93M | 2.17% | $4.76M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Opaleye management | 1.93M | 0.63% | $4.76M |
| Green alpha advisors | 160.14K | 0.39% | $395.55K |
| Gsa capital partners llp | 434.41K | 0.07% | $1.07M |
| Kennedy capital management | 1.05M | 0.06% | $2.60M |
| Eversept partners, lp | 290.92K | 0.04% | $718.57K |
| Hennion & walsh asset management | 263.07K | 0.02% | $649.78K |
| R squared | 12.64K | 0.02% | $31.23K |
| Dlk investment management | 16.62K | 0.02% | $41.05K |
| Renaissance | 3.97M | 0.02% | $9.81M |
| Thrive wealth management | 33.50K | 0.01% | $82.75K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Opaleye management | 1.93M | 0.63% | 1.93M |
| Vanguard group | 8.21M | 0.00% | 1.24M |
| Jpmorgan chase | 1.95M | 0.00% | 1.16M |
| Renaissance | 3.97M | 0.02% | 932.38K |
| D. e. shaw | 1.94M | 0.00% | 834.30K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -4.90M |
| Avidity partners management lp | - | - | -1.47M |
| Balyasny asset management | - | - | -1.30M |
| Pictet asset management sa | - | - | -1.16M |
| Monaco asset management sam | - | - | -1.07M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Opaleye management | 1.93M | 0.63% | 1.93M | $4.76M |
| Mackenzie financial | 730.05K | 0.00% | 730.05K | $1.80M |
| Vanguard fiduciary trust | 614.04K | 0.00% | 614.04K | $1.52M |
| Wellington management group llp | 295.26K | 0.00% | 295.26K | $1.02M |
| Marshall wace, llp | 210.31K | 0.00% | 210.31K | $519.46K |
Sold Out
| Holder | Change |
|---|---|
| Gps wealth strategies group | -2.00 |
| Pacific capital wealth advisors | -5.00 |
| Sittner & nelson | -6.00 |
| Quintet private bank (europe) | -6.00 |
| Baldwin brothers llc/ma | -8.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 163 | -20.87% | 39,288,742 | -8.85% | 43 | 1.67% | 54 | -28.00% | 48 | -17.24% |
| Sep 30, 2025 | 197 | - | 43,075,975 | 4.21% | 51 | 2.13% | 69 | -9.21% | 57 | 11.76% |
| Jun 30, 2025 | 191 | -3.54% | 41,244,466 | -6.30% | 48 | 1.74% | 72 | - | 52 | -8.77% |
| Mar 31, 2025 | 196 | -6.67% | 44,003,328 | -13.78% | 52 | 1.38% | 69 | -27.37% | 59 | -1.67% |
| Dec 31, 2024 | 94 | -60.17% | 19,933,396 | -63.85% | 24 | 0.54% | 38 | -62.00% | 22 | -65.63% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 2.59M | 3.12% | - |
| Vanguard Total Stock Mkt Idx Inv | 3.02M | 3.08% | - |
| iShares Russell 2000 ETF | 2.37M | 2.42% | 53.95K |
| Vanguard Strategic Equity Inv | 1.87M | 1.91% | - |
| Nuveen Quant Small Cap Equity R6 | 1.68M | 1.71% | - |
| Pictet Biopharmaceutical Mother | 1.15M | 1.38% | 42.67K |
| Vanguard Small Cap Index | 1.04M | 1.26% | 2.50K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.08M | 1.10% | - |
| Kennedy Micro Cap | 1.05M | 1.08% | 490.32K |
| Selectra J. Lamarck Biotech A | 988.06K | 1.01% | -126.94K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 03, 2026 | O'Neill Gilmore Neil | CEO | Sell | $10.89K |
| Mar 03, 2026 | Parison Amy | SVP, Chief Financial Officer | Sell | $957.48 |
| Mar 03, 2026 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | $1.51K |
| Dec 03, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | $1.54K |
| Dec 03, 2025 | O'Neill Gilmore Neil | CEO | Sell | $12.06K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 3 |
| 2025 Q4 | - | 3 |
| 2025 Q3 | - | 5 |
| 2025 Q2 | - | 3 |
| 2025 Q1 | - | 3 |
EDIT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools